Who
Jeffrey S. Hackman
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Fennec Pharmaceuticals; See Remarks., Comera Life Sciences Holdings.
In numbers
- Trades disclosed
- 33
- Buys
- 3
- Sells
- 0
- Bought
- $203K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 9 Aug 2022
- Last trade
- 12 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Oct 2026filed 13 Oct 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $12K2,224 at $5.53 | filing |
| 30 Sep 2026filed 1 Oct 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,159 at $0.00 | filing |
| 31 Aug 2026filed 31 Aug 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,159 at $0.00 | filing |
| 31 Aug 2026filed 31 Aug 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,159 at $0.00 | filing |
| 31 Jul 2026filed 3 Aug 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,159 at $0.00 | filing |
| 31 Jul 2026filed 3 Aug 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,159 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,159 at $0.00 | filing |
| 30 Jun 2026filed 1 Jul 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,159 at $0.00 | filing |
| 31 May 2026filed 1 Jun 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,159 at $0.00 | filing |
| 31 May 2026filed 1 Jun 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —1,159 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,159 at $0.00 | filing |
| 30 Apr 2026filed 1 May 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,159 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —16,695 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,159 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | FENC Fennec Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $1.2M200,000 at $5.77 | filing |
| 31 Mar 2026filed 2 Apr 2026 | FENC Fennec Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | $1.2M200,000 at $5.77 | filing |
| 31 Mar 2026filed 2 Apr 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —16,695 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —1,159 at $0.00 | filing |
| 28 Mar 2026filed 2 Apr 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —13,943 at $0.00 | filing |
| 28 Mar 2026filed 2 Apr 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —13,943 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.